ACTRIMS Forum

This year, ACTRIMS held their sixth annual forum virtually. From Feb. 25-27, attendees logged on for presentations related to this year’s meeting theme, “The Spectrum of Multiple Sclerosis.”

Perfect adherence to oral disease-modifying therapy was uncommon in a study of patients with MS that used digital tools to track medication adherence, according to findings presented at the ACTRIMS virtual meeting.

In this video perspective, Benjamin Segal, MD, discusses the Kenneth P. Johnson Memorial Lecture he delivered at the ACTRIMS virtual meeting.

A survey instrument developed to assess disclosure vs. concealment of MS diagnosis identified an association with depression and anxiety, according to research presented at the ACTRIMS virtual meeting.

African American and Hispanic patients with MS were more prone to disability than white patients despite using similar disease-modifying therapies, researchers said.

Patients with MS, healthy controls and health care providers demonstrated increased awareness about the risk for COVID-19 infection, according to results from a cross-sectional survey presented at the ACTRIMS virtual meeting.

Plasma levels of interleukin-1 receptor antagonist correlated with cerebrospinal fluid neurofilament light levels and predicted disability among patients with MS, according to a study presented at the ACTRIMS virtual meeting.

Brain age represented a valuable, volume-based principal component of MRI findings in patients with MS that correlated with information processing speed, according to results presented at ACTRIMS virtual meeting.

Spending more time in sunlight was associated with a significantly reduced risk for pediatric-onset MS, according to findings presented at the ACTRIMS virtual meeting.

Dwight E. Bergles, PhD, received the Barancik Prize for Innovation in MS Research at the ACTRIMS Forum for his research in oligodendrocyte precursor cells, which are involved in remyelination, according to a press release.